<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mCBMs &#8211; St Andrews QV</title>
	<atom:link href="http://standrewsqv.org.uk/tag/mcbms/feed/" rel="self" type="application/rss+xml" />
	<link>http://standrewsqv.org.uk</link>
	<description>Examining the facts behind the issues</description>
	<lastBuildDate>Thu, 30 Apr 2020 08:13:42 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9</generator>

<image>
	<url>http://standrewsqv.org.uk/wp-content/uploads/2018/12/cropped-QV-logo-32x32.png</url>
	<title>mCBMs &#8211; St Andrews QV</title>
	<link>http://standrewsqv.org.uk</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Drug developed by St Andrews spin out company targets COVID-19</title>
		<link>http://standrewsqv.org.uk/2020/04/drug-developed-by-st-andrews-spin-out-company-targets-covid-19/</link>
					<comments>http://standrewsqv.org.uk/2020/04/drug-developed-by-st-andrews-spin-out-company-targets-covid-19/#respond</comments>
		
		<dc:creator><![CDATA[St Andrews Q.V.]]></dc:creator>
		<pubDate>Thu, 30 Apr 2020 08:13:42 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[carbohydrate binding modules]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[mCBMs]]></category>
		<category><![CDATA[Pneumagen]]></category>
		<category><![CDATA[st andrews university]]></category>
		<guid isPermaLink="false">https://standrewsqv.org.uk/?p=2304</guid>

					<description><![CDATA[A new anti-viral drug developed by Pneumagen, a University of St Andrews spin out company, has had positive results in laboratory tests against Covid-19. Pneumagen Ltd, a company focused on treating infectious disease and developing cancer treatments by targeting the carbohydrate component in the cell surface announced (28th April) results from three separate lab studies into &#8230; <br /><br /><a href="http://standrewsqv.org.uk/2020/04/drug-developed-by-st-andrews-spin-out-company-targets-covid-19/" class="more-link">Read more<span class="screen-reader-text"> "Drug developed by St Andrews spin out company targets COVID-19"</span></a>]]></description>
		
					<wfw:commentRss>http://standrewsqv.org.uk/2020/04/drug-developed-by-st-andrews-spin-out-company-targets-covid-19/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
